Definitely good points. The reasoning behind my enthusiasm is that I expect further capital requirements from here (which we will definitely need) will likely be debt financed (Or capital raise if a much higher share price) given we have institutions on board now and have locked in revenues after production. We have significantly de risked the project so it makes sense that we will slowly recover from here. And that’s assuming no black swan events (good or bad) occur between now and needing capital again
- Forums
- ASX - By Stock
- ADN
- James Marsh - MD Interviews
James Marsh - MD Interviews, page-285
-
- There are more pages in this discussion • 304 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 725000 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 3456624 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 725000 | 0.016 |
41 | 7773041 | 0.015 |
14 | 4536049 | 0.014 |
7 | 2633923 | 0.013 |
6 | 1655833 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 3456624 | 11 |
0.018 | 3062774 | 10 |
0.019 | 3659762 | 9 |
0.020 | 1678444 | 14 |
0.021 | 1397619 | 3 |
Last trade - 08.43am 16/07/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online